FDA Expands Use Of Remdesivir To Patients With High Risk Of Hospitalization

PARIS, France – The U.S. health regulator on Friday expanded its approval for the use of Gilead Sciences’ antiviral drug remdesivir to treat non – hospitalized patients 12 years and older for the treatment of mild – to – moderate COVID -19 disease with high risk of hospitalization. Previously, the use of Veklury was limited … More FDA Expands Use Of Remdesivir To Patients With High Risk Of Hospitalization

HEALTH | WHO Study Finds Remdesivir Didn’t Help COVID-19 Patients

GENEVA – A large study led by the World Health Organization suggests that the antiviral drug Remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results announced Friday do not negate the previous ones, … More HEALTH | WHO Study Finds Remdesivir Didn’t Help COVID-19 Patients

NEWS ALERT | FDA Authorizes Remdesivir Drug As Emergency Treatment For COVID-19

WASHINGTON – The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug Remdesivir to treat patients with COVID-19, it said in a letter to Gilead. During a meeting in the Oval Office with President Donald Trump, Gilead Chief Executive Daniel O’Day called the … More NEWS ALERT | FDA Authorizes Remdesivir Drug As Emergency Treatment For COVID-19